Comments on ECHA Guidance on Weight of Evidence and Uncertainty in Hazard Assessment

Provided written input to consultation by ECHA on the redrafting of their guidance for weight-of-evidence assessment of endocrine disruptors. We highlighted importance of use of systematic review methods in evidence assessment. There is greater emphasis on SR methods in the guidance consequent to our intervention, with explicit mention of NTP/OHAT methods and the SYRINA framework, to which we contributed.